ad

Balaxi Pharmaceuticals (BALAXI) Share Price Falls 8.2% in Latest Session

20 Nov 2026 • 9:56 am

Balaxi Pharmaceuticals (BALAXI) Share Price Falls 8.2% in Latest Session
Balaxi Pharmaceuticals (BALAXI) share price fell to Rs 34.24 today, down 8.2% from the previous close. Market cap was Rs 174.73 crore.

Balaxi Pharmaceuticals Share Price is trading at Rs 34.24 after a fall of 8.2% from the previous close, with market capitalisation at Rs 174.73 crore. The move keeps Balaxi Pharmaceuticals Share Price in focus for investors tracking Balaxi Pharmaceuticals Share Price Today, Balaxi Pharmaceuticals Stock News and Balaxi Pharmaceuticals Share Price Fall on Univest. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock opened at Rs 36.49, touched a high of Rs 36.49 and a low of Rs 33.60, so the latest Balaxi Pharmaceuticals Share Price move is best read as a sharp intraday decline rather than a broad multi-day trend. For readers following Balaxi Pharmaceuticals Share Price News, the first question is whether the price action is supported by fundamentals; the next sections address that with valuation, returns and peer context.

Balaxi Pharmaceuticals (BALAXI) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 34.24
Previous Close Rs 37.3
Today's Move -Rs 3.06 (-8.2%)
Open Rs 36.49
High Rs 36.49
Low Rs 33.6
Market Capitalisation Rs 174.73 crore
Market Cap Category Micro Cap

Balaxi Pharmaceuticals Share Price is trading at Rs 34.24, which is Rs 3.06 below the previous close of Rs 37.30. The day change is -8.2%, and the stock moved between an intraday high of Rs 36.49 and a low of Rs 33.60. Balaxi Pharmaceuticals Share Price Today therefore shows a gap between the opening level and the final observed trading level, while the day range also places the stock close to the lower end of the band. The company belongs to the Micro Cap category, with market capitalisation of Rs 174.73 crore. For Balaxi Pharmaceuticals Share Price watchers, the key fact is simple: the stock has lost ground in the latest session and the move is large enough to matter in Balaxi Pharmaceuticals Share Price News and Balaxi Pharmaceuticals Stock Analysis. The next check is whether the fundamentals justify the current Balaxi Pharmaceuticals Share Price valuation.

Balaxi Pharmaceuticals (BALAXI) Fundamental Analysis

Metric Value
Market Capitalisation Rs 174.73 crore
P/E Ratio 61.2x
P/B Ratio 0.81x
ROE 0.59%
ROCE 3.48%
EPS Rs 0.61
Book Value Per Share Rs 46.04
Dividend Yield 0%

Balaxi Pharmaceuticals (BALAXI) fundamental metrics show P/E 61.2x, P/B 0.81x, ROE 0.59%, ROCE 3.48%. Taken on their own, these numbers offer context rather than a trading signal.

Balaxi Pharmaceuticals has a market capitalisation of Rs 174.73 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.2x, P/B at 0.81x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 0.59% and ROCE of 3.48%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.61, book value per share of Rs 46.04, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.46x, median ROE of 4.11%, median ROCE of 6.06%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Trading
Industry Trading
Benchmark Scope same industry
Company P/E Ratio 61.2x
Benchmark Median P/E 22.46x
Benchmark Average P/E 91.1x
Benchmark P/E Range 0.1x to 4,869.11x
Company P/B Ratio 0.81x
Benchmark Median P/B 1.33x
Benchmark Average P/B 1.27x
Company ROE 0.59%
Benchmark Median ROE 4.11%
Benchmark Average ROE 4.24%
Company ROCE 3.48%
Benchmark Median ROCE 6.06%
Benchmark Average ROCE 3.7%
Company Market Capitalisation Rs 174.73 crore
Benchmark Median Market Cap Rs 53.16 crore
Benchmark Average Market Cap Rs 1,506.91 crore

Balaxi Pharmaceuticals (BALAXI) operates in the Trading sector, within the Trading industry.

Balaxi Pharmaceuticals (BALAXI) has a P/E ratio of 61.2x, which is above the benchmark median of 22.46x, a difference of +172.48%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Balaxi Pharmaceuticals (BALAXI) has a ROE of 0.59%, which is below the benchmark median of 4.11%, a difference of -85.64%. Balaxi Pharmaceuticals (BALAXI) has a ROCE of 3.48%, which is below the benchmark median of 6.06%, a difference of -42.57%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Adani Enterprises ADANIENT 3,63,704.65 63.65 3.73 15.07 13.3
ADITYA INFOTECH CPPLUS 48,347.46 83.28 13.45 25.68 29.48
Aegis Logistics AEGISLOG 44,745.74 33.33 4.37 20.71 19.76
Premier Energies PREMIERENE 37,904.95 21.32 7.3 42.6 33.72
Redington REDINGTON 26,427.88 14.39 2.48 13.6 18.96

Balaxi Pharmaceuticals (BALAXI) has a P/E ratio of 61.2x compared with the displayed peer median of 33.33x. The comparison is relative and should not be read as a recommendation. Its ROE of 0.59% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 3.48% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Balaxi Pharmaceuticals (BALAXI) has a market capitalisation of Rs 174.73 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Balaxi Pharmaceuticals

  • Balaxi Pharmaceuticals Share Price is down 8.2% in the latest session, and the move is large enough to stand out in Balaxi Pharmaceuticals Share Price Today coverage.
  • The stock is trading at Rs 34.24 after opening at Rs 36.49 and touching Rs 33.60, so Balaxi Pharmaceuticals Share Price remains active within a defined intraday band.
  • Balaxi Pharmaceuticals Share Price carries a P/E of 61.2 and a P/B of 0.81, giving investors a mixed valuation picture to assess.
  • ROE of 0.59% and ROCE of 3.48% keep the focus on return efficiency in Balaxi Pharmaceuticals Fundamental Analysis.
  • Balaxi Pharmaceuticals Share Price sits in the Micro Cap category, and the company’s market capitalisation is Rs 174.73 crore.

About Balaxi Pharmaceuticals

Balaxi Pharmaceuticals operates in the Trading sector and Trading industry. The latest company context available to Univest readers places Balaxi Pharmaceuticals Share Price within a business model framed by trading activity rather than a diversified operating profile. For Balaxi Pharmaceuticals Share Price News, that matters because traders and investors often read the stock through valuation, return ratios and market-cap placement rather than through large-scale operating disclosures. Balaxi Pharmaceuticals Share Price therefore sits in a niche where market capitalisation, P/E, P/B, ROE, ROCE, EPS and book value are the main reference points in this article. The company’s latest share-price move is the event in focus, while its sector placement provides the broader context for Balaxi Pharmaceuticals Share Price Today.

Track Balaxi Pharmaceuticals Share Price on Univest

Use Balaxi Pharmaceuticals (BALAXI) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Univest helps readers track Balaxi Pharmaceuticals Share Price with live price updates, fundamental ratios, 52-week levels and market insights in one place. If you are following Balaxi Pharmaceuticals Share Price Today, you can use Univest to review price action, valuation context and company overview without switching between multiple sources. Balaxi Pharmaceuticals Share Price remains relevant for investors who monitor stock movements, sector context and company-specific financial ratios on a single platform.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Balaxi Pharmaceuticals Share Price today?

Ans. Balaxi Pharmaceuticals Share Price is trading at Rs 34.24. The stock is down 8.2% from the previous close of Rs 37.30, which keeps Balaxi Pharmaceuticals Share Price Today in focus for readers tracking the latest move.

Why did Balaxi Pharmaceuticals Share Price fall today?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. Balaxi Pharmaceuticals Share Price fell 8.2% in the latest session, and the visible figures show only the move, not a verified trigger.

What was the previous close for Balaxi Pharmaceuticals Share Price?

Ans. The previous close for Balaxi Pharmaceuticals Share Price was Rs 37.30. The stock then moved to Rs 34.24, creating a day change of Rs 3.06 lower and a percentage decline of 8.2%.

What is the market capitalisation of Balaxi Pharmaceuticals?

Ans. Balaxi Pharmaceuticals has a market capitalisation of Rs 174.73 crore. That places Balaxi Pharmaceuticals Share Price in the Micro Cap category and well below the average market cap in the same-industry benchmark.

How is Balaxi Pharmaceuticals Share Price valued?

Ans. Balaxi Pharmaceuticals Share Price trades at a P/E of 61.2 and a P/B of 0.81. The earnings multiple is above the benchmark median, while the book-value multiple is below the benchmark median, creating a mixed valuation setup.

What do ROE and ROCE show for Balaxi Pharmaceuticals?

Ans. Balaxi Pharmaceuticals reports ROE of 0.59% and ROCE of 3.48%. Both ratios are below the benchmark medians for the Trading industry, so Balaxi Pharmaceuticals Share Price is not backed by strong return ratios in the current figures.

Does Balaxi Pharmaceuticals pay a dividend?

Ans. The dividend yield is 0% for Balaxi Pharmaceuticals. That means Balaxi Pharmaceuticals Share Price does not currently have a dividend yield figure supporting the stock, so investors are reading it mainly through valuation and return metrics.

How does Balaxi Pharmaceuticals compare with Trading peers?

Ans. Balaxi Pharmaceuticals Share Price has a much smaller market cap than the selected peers, and its ROE and ROCE are lower than all five comparison names. Its P/E is below some peers and above others, so the comparison is mixed.

Should investors track Balaxi Pharmaceuticals Share Price on Univest?

Ans. Yes, investors tracking Balaxi Pharmaceuticals Share Price can use Univest for live price updates, valuation ratios and market context. The stock’s latest decline, micro-cap size and peer comparison make it a useful name to monitor closely.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down